4,220 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Bought by Alps Advisors Inc.

Alps Advisors Inc. acquired a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 4,220 shares of the medical instruments supplier's stock, valued at approximately $354,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Principal Financial Group Inc. lifted its position in shares of LeMaitre Vascular by 3.0% during the 1st quarter. Principal Financial Group Inc. now owns 111,865 shares of the medical instruments supplier's stock valued at $9,385,000 after acquiring an additional 3,248 shares during the period. Invesco Ltd. lifted its position in shares of LeMaitre Vascular by 50.5% during the 4th quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier's stock valued at $16,124,000 after acquiring an additional 58,720 shares during the period. Compass Planning Associates Inc lifted its position in shares of LeMaitre Vascular by 91.4% during the 1st quarter. Compass Planning Associates Inc now owns 11,776 shares of the medical instruments supplier's stock valued at $988,000 after acquiring an additional 5,623 shares during the period. Johnson Investment Counsel Inc. lifted its position in shares of LeMaitre Vascular by 34.8% during the 1st quarter. Johnson Investment Counsel Inc. now owns 29,428 shares of the medical instruments supplier's stock valued at $2,469,000 after acquiring an additional 7,603 shares during the period. Finally, Teacher Retirement System of Texas lifted its position in shares of LeMaitre Vascular by 31.8% during the 4th quarter. Teacher Retirement System of Texas now owns 101,851 shares of the medical instruments supplier's stock valued at $9,385,000 after acquiring an additional 24,586 shares during the period. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 76,868 shares of LeMaitre Vascular stock in a transaction on Monday, May 19th. The shares were sold at an average price of $85.79, for a total value of $6,594,505.72. Following the sale, the chief executive officer owned 1,796,783 shares in the company, valued at $154,146,013.57. The trade was a 4.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold 100,000 shares of company stock valued at $8,556,857 over the last quarter. 9.50% of the stock is owned by insiders.

LeMaitre Vascular Stock Down 2.8%

Shares of LMAT stock traded down $2.33 on Friday, hitting $79.77. The stock had a trading volume of 121,008 shares, compared to its average volume of 169,186. The business has a 50 day moving average of $82.82 and a 200 day moving average of $87.74. The stock has a market cap of $1.80 billion, a price-to-earnings ratio of 40.29, a price-to-earnings-growth ratio of 2.10 and a beta of 0.82. The company has a debt-to-equity ratio of 0.48, a current ratio of 16.49 and a quick ratio of 13.83. LeMaitre Vascular, Inc. has a 12-month low of $71.42 and a 12-month high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The business had revenue of $59.87 million for the quarter, compared to the consensus estimate of $57.61 million. During the same quarter in the prior year, the business earned $0.44 EPS. LeMaitre Vascular's revenue for the quarter was up 12.0% compared to the same quarter last year. As a group, analysts expect that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.00%. The ex-dividend date was Thursday, May 15th. LeMaitre Vascular's payout ratio is 40.40%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.